J2357 Omalizumab injection
Also known as: omalizumab, Xolair, IgE antibody
Injection of omalizumab. A monoclonal antibody against immunoglobulin E for allergic asthma.
In Plain Language
allergy and asthma control; allergy antibody blocker
Clinical Context
Used for moderate-to-severe allergic asthma and chronic idiopathic urticaria. Omalizumab binds IgE reducing allergic responses.
RVU Information
CPT J2357 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2357?
CPT J2357 (Omalizumab injection) is a J Codes (Drugs) code. Injection of omalizumab. A monoclonal antibody against immunoglobulin E for allergic asthma.
How is J2357 administered?
CPT J2357 is administered by a healthcare provider, typically via injection or infusion. Used for moderate-to-severe allergic asthma and chronic idiopathic urticaria. Omalizumab binds IgE reducing allergic responses. It is used by Pulmonology, Allergy/Immunology.
When is CPT J2357 used?
Used for moderate-to-severe allergic asthma and chronic idiopathic urticaria. Omalizumab binds IgE reducing allergic responses.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.